Oruka Therapeutics (HQ1.F) Q4 2024 Earnings

13NovConfirmed
Q3 2024
Q4 2024
-1.38
-1.05
-0.71
-0.38

Details

Expected EPS
-0.38046265399999996
Actual EPS
-1.3821236
Surprise EPS
-1
Surprise Percent
+263.27%

Description

Oruka Therapeutics (HQ1.F) has reported earnings of -1.3821236 per share for Q4 2024.

0 Comments

Share your thoughts